C M Bidwell & Associates LTD Amicus Therapeutics, Inc. Transaction History

C M Bidwell & Associates LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$9.82 - $12.75 $589 - $765	-60 Reduced 21.82%	215 $2,000
Q1 2022 Apr 29, 2022	SELL	$7.89 - $12.48 $158,115 - $250,099	-20,040 Reduced 98.65%	275 $3,000
Q4 2021 Feb 11, 2022	BUY	$9.82 - $12.44 $199,493 - $252,718	20,315 New	20,315 $235,000
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $159,215 - $294,199	-11,820 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$6.63 - $11.16 $78,366 - $131,911	11,820 New	11,820 $109,000

306

283M

467K

515K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $1.94B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.